Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)
Also known as: Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia / Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB15699 | Brexucabtagene autoleucel | 1 / 2 | Completed | 1 |
DB15699 | Brexucabtagene autoleucel | 1 / 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Completed | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
DB01073 | Fludarabine | 1 / 2 | Completed | 1 |
DB01073 | Fludarabine | 1 / 2 | Recruiting | 1 |
DB09052 | Blinatumomab | 2 | Not Yet Recruiting | 1 |
DB15699 | Brexucabtagene autoleucel | 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
DB01073 | Fludarabine | 2 | Recruiting | 1 |
DB09052 | Blinatumomab | 3 | Terminated | 1 |
DB09052 | Blinatumomab | Not Available | No Longer Available | 1 |